HomeALPMF • OTCMKTS
add
Astellas Pharma Inc
Nakaraang pagsara
$10.60
Sakop ng taon
$9.13 - $12.74
Market cap
2.83T JPY
Average na Volume
858.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 462.50B | 17.94% |
Gastos sa pagpapatakbo | 341.78B | 7.88% |
Net na kita | 35.91B | 1,239.35% |
Net profit margin | 7.76 | 1,041.18% |
Kita sa bawat share | — | — |
EBITDA | 88.05B | 120.73% |
Aktuwal na % ng binabayarang buwis | 6.85% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 292.99B | -12.28% |
Kabuuang asset | 3.46T | -2.28% |
Kabuuang sagutin | 1.93T | 1.51% |
Kabuuang equity | 1.53T | — |
Natitirang share | 1.79B | — |
Presyo para makapag-book | 0.01 | — |
Return on assets | 2.64% | — |
Return on capital | 3.70% | — |
Cash Flow
Net change in cash
| (JPY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 35.91B | 1,239.35% |
Cash mula sa mga operasyon | 64.81B | 75.72% |
Cash mula sa pag-invest | -16.38B | 97.88% |
Cash mula sa financing | -54.34B | -110.76% |
Net change in cash | -9.94B | 95.63% |
Malayang cash flow | 43.59B | -17.69% |
Tungkol
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Itinatag
Abr 1, 2005
Headquarters
Website
Mga Empleyado
14,754
